Skip to main content
David Alland, MD, Infectious Disease, Newark, NJ

DavidAllandMD

Infectious Disease Newark, NJ

Professor, Medicine, UMDNJ-New Jersey Medical School

Dr. Alland is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Alland's full profile

Already have an account?

  • Office

    150 Bergen St
    Newark, NJ 07103
    Phone+1 973-972-2179
    Fax+1 973-972-6804

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 1988 - 1992
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1984 - 1987
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1984

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2001 - 2025
  • VA State Medical License
    VA State Medical License 2017 - 2020
  • FL State Medical License
    FL State Medical License 2017 - 2019
  • TX State Medical License
    TX State Medical License 2017 - 2018
  • NY State Medical License
    NY State Medical License 1986 - 2003
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Journal Articles

  • Bacterial Factors That Predict Relapse After Tuberculosis Therapy  
    David Alland, MD, The New England Journal of Medicine
  • Bacterial Factors That Predict Relapse After Tuberculosis Therapy  
    David Alland, W Henry Boom, The New England Journal of Medicine

Press Mentions

  • Pfizer, Moderna Shots Safe During in Vitro Fertilization; Healthy Gut Bacteria May Help Prevent Long COVID
    Pfizer, Moderna Shots Safe During in Vitro Fertilization; Healthy Gut Bacteria May Help Prevent Long COVIDJanuary 27th, 2022
  • This New Testing Kit Can Detect Any COVID-19 Variant in Minutes
    This New Testing Kit Can Detect Any COVID-19 Variant in MinutesJanuary 27th, 2022
  • Pfizer, Moderna Draws Safely During in Vitro Fertilization; Healthy Gut Bacteria May Help Prevent Long COVID
    Pfizer, Moderna Draws Safely During in Vitro Fertilization; Healthy Gut Bacteria May Help Prevent Long COVIDJanuary 26th, 2022
  • Join now to see all

Grant Support

  • On Demand Blood Tests For Select Agent DiagnosisNational Institute Of Allergy And Infectious Diseases2012
  • Development Of A Second Generation Mdr-Xdr TB AssayNational Institute Of Allergy And Infectious Diseases2009–2012
  • Rapid Diagnosis Of XDR TuberculosisNational Institute Of Allergy And Infectious Diseases2009–2011
  • Development Of A Molecular Blood CultureNational Institute Of Allergy And Infectious Diseases2009–2010
  • Afb Smears For Drug Resistance Detection And Surveillance In MTB.National Institute Of Allergy And Infectious Diseases2009–2010
  • Integrated Dual-Use Systems For Bio-Defense &Sepsis DiagnosisNational Institute Of Allergy And Infectious Diseases2007–2010
  • Sample Processing Cartridges For Rapid PCR TB DetectionNational Institute Of Allergy And Infectious Diseases2006–2008
  • Detection Of Select Agents In Single-Well AssaysNational Institute Of Allergy And Infectious Diseases2003–2007
  • Towards Drugs That Prevent Resistance To The HIV Oi, TBNational Institute Of Allergy And Infectious Diseases2005–2006
  • Tuberculosis Genotyping And Evolutionary ConsortiumNational Institute Of Allergy And Infectious Diseases2002–2005
  • Population Based Investigations Of TuberculosisNational Institute Of Allergy And Infectious Diseases2001–2004
  • Sample Processing Cartridges For Rapid PCR TB DetectionNational Institute Of Allergy And Infectious Diseases2002
  • Population Based Investigations Of TuberculosisNational Institute Of Allergy And Infectious Diseases2000–2001
  • Tuberculosis Curriculum For An Urban Medical CenterNational Heart, Lung, And Blood Institute1997–2000